Back to Search
Start Over
A randomized phase II trial of carboplatin with or without nivolumab in first- or second-line metastatic TNBC
- Source :
- Journal of Clinical Oncology. 36:TPS1118-TPS1118
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- TPS1118Background: Triple negative breast cancer (TNBC) has an aggressive clinical course with higher relapse rates and shorter overall survival compared to patients with hormone receptor-positive ...
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Clinical course
Carboplatin
03 medical and health sciences
chemistry.chemical_compound
030104 developmental biology
0302 clinical medicine
Second line
chemistry
030220 oncology & carcinogenesis
Internal medicine
medicine
Overall survival
Nivolumab
business
Triple-negative breast cancer
Hormone
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........964ad6c2e884d8a2d59137837f4be359
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.tps1118